The authors present the results of a survey of small- and large-molecule pharmaceutical and biopharmaceutical companies on implementation of Analytical quality by design concepts.
Andy Rignall
Advertisement
Articles by Andy Rignall
IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development, with a focus on stability.
IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development.
Advertisement
Latest Updated Articles
Early Development GMPs for Stability (Part IV)September 2nd 2012
Evaluating Progress in Analytical Quality by DesignApril 2nd 2017
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Manufacturing Intelligence Episode 4: Cleanroom Digital Twins
2
GSK's Momelotinib Pursues Rare VEXAS Syndrome Indication
3
PharmTech Weekly Roundup—June 12, 2026
4
Manufacturing Intelligence: How Digital Twins Are Changing Cleanroom Validation
5